Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$98.98 - $115.74 $2,870 - $3,356
-29 Reduced 7.63%
351 $40,000
Q2 2023

Aug 03, 2023

BUY
$96.34 - $112.38 $2,793 - $3,259
29 Added 8.26%
380 $39,000
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $2,146 - $2,270
-20 Reduced 5.39%
351 $38,000
Q3 2022

Nov 09, 2022

SELL
$58.92 - $84.67 $7,777 - $11,176
-132 Reduced 26.24%
371 $21,000
Q2 2022

Aug 02, 2022

BUY
$79.4 - $116.36 $1,111 - $1,629
14 Added 2.86%
503 $40,000
Q1 2022

May 10, 2022

SELL
$86.42 - $109.81 $70,173 - $89,165
-812 Reduced 62.41%
489 $52,000
Q4 2021

Feb 09, 2022

SELL
$98.56 - $119.91 $8,081 - $9,832
-82 Reduced 5.93%
1,301 $140,000
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $64,337 - $77,259
700 Added 102.49%
1,383 $151,000
Q3 2021

Nov 09, 2021

SELL
$91.91 - $110.37 $21,139 - $25,385
-230 Reduced 25.19%
683 $74,000
Q2 2021

Aug 09, 2021

SELL
$86.24 - $95.92 $6,899 - $7,673
-80 Reduced 8.06%
913 $85,000
Q1 2021

May 11, 2021

BUY
$71.83 - $95.48 $66,155 - $87,937
921 Added 1279.17%
993 $91,000
Q4 2020

Feb 11, 2021

SELL
$67.0 - $84.39 $2,814 - $3,544
-42 Reduced 36.84%
72 $5,000
Q3 2020

Nov 12, 2020

SELL
$55.23 - $79.93 $3,700 - $5,355
-67 Reduced 37.02%
114 $8,000
Q2 2020

Jul 31, 2020

SELL
$30.2 - $56.98 $3,775 - $7,122
-125 Reduced 40.85%
181 $10,000
Q1 2020

May 05, 2020

SELL
$24.87 - $38.56 $6,118 - $9,485
-246 Reduced 44.57%
306 $9,000
Q3 2019

Oct 23, 2019

BUY
$23.0 - $27.97 $12,696 - $15,439
552 New
552 $15,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.